Showing results (11-20 of 145) with videos related to
Sort By:
Pageof 15
Inflammation|April 1, 1990
Compartmental heterogeneity of soluble phospholipases AP Vadas, W Pruzanski, E Stefanski, et al.Journal of Lipid Mediators|August 1, 1993
Extracellular phospholipase A2 expression and inflammation: the relationship with associated disease statesP Vadas, J Browning, J Edelson, et al.Journal of Biochemistry|November 1, 1986
Purification of a soluble phospholipase A2 from synovial fluid in rheumatoid arthritisE Stefanski, W Pruzanski, B Sternby, et al.The Journal of Rheumatology. Supplement|February 1, 1991
The role of phospholipase A2 in the physiopathology of osteoarthritisW Pruzanski, E Bogoch, M Wloch, et al.The American Journal of Pathology|April 1, 1989
The proinflammatory effect of intra-articular injection of soluble human and venom phospholipase A2P Vadas, W Pruzanski, J Kim, et al.Inflammation|April 1, 1991
Comparison of group I and II soluble phospholipases A2 activities on phagocytic functions of human polymorphonuclear and mononuclear phagocytesW Pruzanski, S Saito, E Stefanski, et al.The Journal of Rheumatology|April 1, 1985
Phospholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzymeW Pruzanski, P Vadas, E Stefanski, et al.Biochemical Pharmacology|June 15, 1997
Inhibition of extracellular release of proinflammatory secretory phospholipase A2 (sPLA2) by sulfasalazine: a novel mechanism of anti-inflammatory activityW Pruzanski, E Stefanski, P Vadas, et al.The Journal of Rheumatology|October 1, 1995
Induction of TNF-alpha and proinflammatory secretory phospholipase A2 by intravenous administration of CAMPATH-1H in patients with rheumatoid arthritisW Pruzanski, M B Urowitz, B Grouix, et al.The Journal of Rheumatology|January 1, 1988
Phospholipase A2 activity associated with synovial fluid cellsW Pruzanski, P Vadas, J Kim, et al.Pageof 15